Abstract
Among the 21 million people in the world with schizophrenia, the risk of suicide is high. Some studies indicate that about ΒΌ of schizophrenics will attempt suicide, while others place the estimate higher. There is agreement that the time between diagnosis and engagement with evidence-based treatment for first-episode psychosis is a time of high risk for suicide. Early identification and intervention can be helpful, and protective factors can be strengthened. The chapter discusses screening and assessment instruments specific to psychosis and suicide. Connecting with treatment providers early after the discovery of psychosis is key, as is working with a psychiatrist to find the most helpful medication regimen. Evidence-based treatments are reviewed. It is recommended that patients with psychosis should be carefully monitored for suicide risk.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization. Schizophrenia: fact sheet. 2016. http://www.who.int/mediacentre/factsheets/fs397/en/.
National Institute of Mental Health. Schizophrenia. 2017. https://www.nimh.nih.gov/health/publications/schizophrenia-booklet/index.shtml.
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30(1):67β76.
Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141.
Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97(1):12β7.
McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2(1):13.
Zhang XY, Chen DC, Xiu MH, Yang FD, Haile CN, Kosten TA, et al. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients. J Clin Psychiatry. 2012;73(7):1025β33.
Mathers CD, Stein C, Ma Fat D, Rao C, Inoue M, Tomijima N, et al. Global Burden of Disease 2000: version 2 methods and results. Geneva: World Health Organization; 2002. http://www.who.int/healthinfo/paper50.pdf
Wijngaarden van B, Schene AH, Koeter M, Vazquez-Barquero JL, Knudsen HC, Lasalvia A, et al. Caregiving in schizophrenia: development, internal consistency and reliability of the Involvement Evaluation Questionnaire-European Version. Br J Psychiatry. 2000;77(39):s21β7.
Nordentoft M, Laursen TM, Agerbo E, Qin P, HΓΈyer EH, Mortensen PB. Change in suicide rates for patients with schizophrenia in Denmark, 1981β97: nested case-control study. BMJ. 2004;329(7460):261.
Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247β53.
Andreasen NC, Black DW, editors. Introductory textbook of psychiatry. 4th ed. Arlington: American Psychiatric Publishing; 2006.
Siris SG. Suicide and schizophrenia. J Psychopharmacol. 2001;15(2):127β35.
Pompili M, Mancinelli I, Tatarelli R. Suicide and schizophrenia. Psych Serv. 2003;54(5):747β8.
Joa I, Johannessen JO, Langeveld J, Friis S, Melle I, Opjordsmoen S, et al. Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand. 2009;119(6):494β500.
Munk-JΓΈrgensen P, Mortensen PB. Social outcome in schizophrenia: a 13-year follow-up. Soc Psychiatry Psychiatr Epidemiol. 1992;27(3):129β34.
Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171(6):502β8.
Haw C, Hawton K, Sutton L, Sinclair J, Deeks J. Schizophrenia and deliberate self-harm: a systematic review of risk factors. Suicide Life Threat Behav. 2005;35(1):50β62.
Montross LP, Zisook S, Kasckow J. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann Clin Psychiatry. 2005;17(3):173β82.
Barrett EA, Sundet K, Faerden A, NesvΓ₯g R, Agartz I, Fosse R, et al. Suicidality before and in the early phases of first episode psychosis. Schizophr Res. 2010;119(1):11β7.
Melle I, Ann Barrett E. Insight and suicidal behavior in first-episode schizophrenia. Expert Rev Neurother. 2012;12(3):353β9.
Falcone T, Mishra L, Carlton E, Lee C, Butler R, Janigro D, et al. Suicidal behavior in adolescents with first-episode psychosis. Clin Schizophr Relat Psychoses. 2010;4(1):34β40.
Kelleher I, Corcoran P, Keeley H, Wigman JT, Devlin N, Ramsay H, et al. Psychotic symptoms and population risk for suicide attempt: a prospective cohort study. JAMA Psychiat. 2013;70(9):940β8.
Madsen T, Karstoft KI, Secher RG, Austin SF, Nordentoft M. Trajectories of suicidal ideation in patients with first-episode psychosis: secondary analysis of data from the OPUS trial. Lancet Psychiatry. 2016;3(5):443β50.
US Public Health Service. The Surgeon Generalβs call to action to prevent suicide. Washington, DC: US Department of Health and Human Services; 1999. http://www.surgeongeneral.gov/library/calltoaction/default.htm
Harkavy-Friedman J. Suicide risk among people with psychosis: focus on first episode. SAMHSA sponsored webinar; June 28, 2016. https://www.nasmhpd.org/content/part-i-recognizing-suicidal-ideation-and-behavior-individuals-first-episode-psychosis.
Bilsker D, White J. The silent epidemic of male suicide. B C Med J. 2011;53(10):529β34.
Grover S, Davuluri T, Chakrabarti S. Religion, spirituality, and schizophrenia: a review. Indian J Psychol Med. 2014;36(2):119β24.
Culliford L. Spirituality and clinical care: spiritual values and skills are increasingly recognised as necessary aspects of clinical care. BMJ. 2002;325(7378):1434β6.
Shah R, Kulhara P, Grover S, Kumar S, Malhotra R, Tyagi S. Contribution of spirituality to quality of life in patients with residual schizophrenia. Psychiatry Res. 2011;190(2):200β5.
Cowen EL, Wyman PA, Work WC. Resilience in highly stressed urban children: concepts and findings. Bull N Y Acad Med. 1996;73(2):267β84.
Kraus N, Chandrasekaran B. Music training for the development of auditory skills. Nat Rev Neurosci. 2010;11(8):599β605.
Simon TR, Swann AC, Powell KE, Potter LB, Kresnow MJ, OβCarroll PW. Characteristics of impulsive suicide attempts and attempters. Suicide Life Threat Behav. 2001;32:49β59.
Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev. 2008;30(1):133β54.
Fleegler EW, Lee LK, Monuteaux MC, Hemenway D, Mannix R. Firearm legislation and firearm-related fatalities in the United States. JAMA Intern Med. 2013;173(9):732β40.
Barrett T. House rolls back Obama gun background check rule. CNN Politics. 3 Feb 2017. http://www.cnn.com/2017/02/02/politics/house-vote-guns-mental-illnesses/.
Sundararaman R, Panangala SV, Lister SA. Suicide prevention among veterans: congressionalΒ research service report to Congress. Congressional Research Service: Washington, DC;Β 2008.
Osman A, Bagge CL, Gutierrez PM, Konick LC, Kopper BA, Barrios FX. The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples. Assessment. 2001;8(4):443β54.
Preston E, Hansen L. A systematic review of suicide rating scales in schizophrenia. Crisis. 2005;26(4):170β80.
Taiminen T, Huttunen J, HeilΓ€ H, Henriksson M, IsometsΓ€ E, KΓ€hkΓΆnen J, et al. The Schizophrenia Suicide Risk Scale (SSRS): development and initial validation. Schizophr Res. 2001;47(2):199β213.
Kasckow J, Felmet K, Zisook S. Managing suicide risk in patients with schizophrenia. CNS Drugs. 2011;25(2):129β43.
Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, et al. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial. J Clin Psychiatry. 2010;71(7):915β22.
Zisook S, Kasckow JW, Golshan S, Fellows I, Solorzano E, Lehman D, et al. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J Clin Psychiatry. 2009;70(4):562β71.
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The ColumbiaβSuicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266β77.
Niendam T. Integrating the C-SSRS into FEP clinical practice. SAMHSA sponsored webinar; June 28, 2016. https://www.nasmhpd.org/content/part-i-recognizing-suicidal-ideation-and-behavior-individuals-first-episode-psychosis.
Lindenmayer JP, Czobor P, Alphs L, Nathan AM, Anand R, Islam Z, et al. The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res. 2003;63(1):161β70.
Beck AT, Steer RA, Ranieri WF. Scale for suicide ideation: psychometric properties of a self-report version. J Clin Psychol. 1988;44(4):499β505.
Pinninti N, Steer RA, Rissmiller DJ, Nelson S, Beck AT. Use of the Beck Scale for suicide ideation with psychiatric inpatients diagnosed with schizophrenia, schizoaffective, or bipolar disorders. Behav Res Ther. 2002;40(9):1071β9.
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82β91.
Ayer DW, Jayathilake K, Meltzer HY. The InterSePT suicide scale for prediction of imminent suicidal behaviors. Psychiatry Res. 2008;161(1):87β96.
Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187(1):9β20.
Hunt IM, Kapur N, Robinson J, Shaw J, Flynn S, Bailey H, et al. Suicide within 12 months of mental health service contact in different age and diagnostic groups. Br J Psychiatry. 2006;188(2):135β42.
Melle I, Johannesen JO, Friis S, Haahr U, Joa I, Larsen TK, et al. Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry. 2006;163(5):800β4.
Kreyenbuhl JA, Medoff DR, McEvoy JP, Smith TE, Hackman AL, Nossel IR, et al. The RAISE connection program: psychopharmacological treatment of people with a first episode of schizophrenia. Psychiatr Serv. 2016;67(12):1300β6.
Beck AT. Cognitive therapy: nature and relation to behavior therapy. Behav Ther. 1970;1(2):184β200.
Bateman K, Hansen L, Turkington D, Kingdon D. Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. Suicide Life Threat Behav. 2007;37(3):284β90.
Zimmermann G, Favrod J, Trieu VH, Pomini V. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res. 2005;77(1):1β9.
Startup M, Jackson MC, Bendix S. North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychol Med. 2004;34(03):413β22.
Tarrier N, Kelly J, Maqsood S, Snelson N, Maxwell J, Law H, et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophr Res. 2014;156(2):204β10.
Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, Kinderman P, et al. Cognitive-behavioural therapy in first-episode and early schizophrenia. Br J Psychiatry. 2004;184(3):231β9.
Henggeler SW, Schoenwald SK, Borduin CM, Rowland MD, Cunningham PB. Multisystemic treatment of antisocial behavior in children and adolescents. New York: Guilford; 1998.
Henggeler SW, Rowland MD, Randall J, Ward DM, Pickrel SG, Cunningham PB, et al. Home-based multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis: clinical outcomes. J Am Acad Child Adolesc Psychiatry. 1999;38(11):1331β9.
Huey SJ, Henggeler SW, Rowland MD, Halliday-Boykins CA, Cunningham PB, Pickrel SG, et al. Multisystemic therapy effects on attempted suicide by youths presenting psychiatric emergencies. J Am Acad Child Adolesc Psychiatry. 2004;43(2):183β90.
Remington G, Kapur S, Zipursky R. APA practice guideline for schizophrenia: risperidone equivalents. Am J Psychiatry. 1998;155(9):1301β2.
Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 1999;156(4):544β9.
Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005;162(5):947β53.
Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry. 1986;148(2):120β7.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209β23.
McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163(4):600β10.
Schooler NR. Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry. 2003;64:14β7.
Essock SM, Covell NH, Davis SM, Stroup TS, Rosenheck RA, Lieberman JA. Effectiveness of switching antipsychotic medications. Am J Psychiatry. 2006;163(12):2090β5.
HeilΓ€ H, IsometsΓ€ ET, Henriksson MM, Heikkinen ME, Marttunen MJ, LΓΆnnqvist JK. Suicide victims with schizophrenia in different treatment phases and adequacy of antipsychotic medication. J Clin Psychiatry. 1999;60(3):200β8.
Forrester T, Siskind D, Winckel K, Wheeler A, Hollingworth S. Increasing clozapine dispensing trends in Queensland, Australia 2004β2013. Pharmacopsychiatry. 2015;48:164β9.
Pankowski D, Kowalski J, GawΔda Ε. SkutecznoΕΔ treningu metapoznawczego u osΓ³b chorujΔ cych na schizofreniΔ: narracyjny przeglΔ d systematyczny badaΕ opublikowanych w latach 2009β2015. Psychiatr Pol. 2016;50(4):787β803.
Rapp CA, Goscha RJ. The principles of effective case management of mental health services. Psychiatr Rehabil J. 2004;27(4):319.
Brown GW. Experiences of discharged chronic schizophrenic mental hospital patients in various types of living groups. Milbank Mem Fund Q. 1959;37:105β31.
Goldstein MJ, Rodnick EH, Evans JR, May PR, Steinberg MR. Drug and family therapy in the aftercare of acute schizophrenics. Arch Gen Psychiatry. 1978;35(10):1169β77.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Β© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Falcone, T., Staniskyte, M., Timmons-Mitchell, J. (2018). Psychosis and Suicide. In: Falcone, T., Timmons-Mitchell, J. (eds) Suicide Prevention. Springer, Cham. https://doi.org/10.1007/978-3-319-74391-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-74391-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74390-5
Online ISBN: 978-3-319-74391-2
eBook Packages: MedicineMedicine (R0)